Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sight Intelligence develops advanced AI-driven software platforms aimed at diagnosing and treating vision disorders as well as improving human visual performance. The company focuses on transforming data into actionable insights to support better outcomes in eye health. No clinical trial results are referenced; the company appears focused on commercial deployment rather than drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sight Intelligence Engineering.